Takeda Pharmaceutical (TAK) Capital Expenditures (2018 - 2026)
Takeda Pharmaceutical's Capital Expenditures was -$337.6 million in the quarter ended Jun 30, 2026, compared with -$331.13 million a year earlier.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Capital Expenditures (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Takeda Pharmaceutical's Capital Expenditures was -$1.18 billion through Jun 30, 2026; for the year ended Mar 31, 2026, it came in at -$1.17 billion.
- In earlier years, Capital Expenditures was -$1.32 billion in the year ended Mar 31, 2025, -$1.22 billion in the year ended Mar 31, 2024, -$1.04 billion in the year ended Mar 31, 2023 and -$1.1 billion in the year ended Mar 31, 2022.
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Capital Expenditures since the quarter ended Jun 30, 2024.
- Per Business Quant data, TAK's Capital Expenditures in the three quarters before the quarter ended Jun 30, 2026 was -$295.63 million (quarter ended Mar 31, 2026), -$270.53 million (quarter ended Dec 31, 2025) and -$272.12 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | -337.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -337.60 Mn |
| Mar 31, 2026 | -295.63 Mn |
| Dec 31, 2025 | -270.53 Mn |
| Sep 30, 2025 | -272.12 Mn |
| Jun 30, 2025 | -331.13 Mn |
| Mar 31, 2025 | -319.82 Mn |
| Dec 31, 2024 | -296.58 Mn |
| Sep 30, 2024 | -331.67 Mn |
| Jun 30, 2024 | -369.00 Mn |
| Mar 31, 2024 | -300.52 Mn |
| Dec 31, 2023 | -318.51 Mn |
| Sep 30, 2023 | -262.07 Mn |
| Jun 30, 2023 | -335.34 Mn |
| Mar 31, 2023 | -270.41 Mn |
| Dec 31, 2022 | -236.88 Mn |
| Sep 30, 2022 | -212.13 Mn |
| Jun 30, 2022 | -325.73 Mn |
| Jun 30, 2021 | -272.57 Mn |
| Mar 31, 2021 | -341.67 Mn |
| Jun 30, 2020 | -215.11 Mn |
API Access
Takeda Pharmaceutical Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();